Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts.
Copley
J B
JB
Department of Internal Medicine, Ochsner Clinic, New Orleans, LA 70121, USA.
Staffeld
C
C
Lindberg
J
J
Hansen
A
A
Bailey
C
C
Anand
R
R
Van Veldhuisen
P
P
D001794:Blood Pressure / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D006937:Hypercholesterolemia / Q000139:chemically induced / Q000453:epidemiology; D006949:Hyperlipidemias / Q000139:chemically induced / Q000517:prevention & control; D006973:Hypertension / Q000139:chemically induced* / Q000517:prevention & control; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008055:Lipids / Q000097:blood*; D015995:Prevalence; D016559:Tacrolimus / Q000627:therapeutic use*
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D007166:Immunosuppressive Agents; D008055:Lipids; D016572:Cyclosporine; D002784:Cholesterol; D016559:Tacrolimus